Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies
NCT07282548
·
clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Withdrawn prior to enrolment after review of updated safety data
Conditions
Follicular Lymphoma
Sponsor
Ipsen